Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 23 Apr 2002, 0:00 Indequity Group Limited - Interim Results
Indequity Group Limited
("Indequity" or "the Group")
(Incorporated in the Republic of South Africa)
Regsitration number: 1998/015883/06
Share Code:  IDQ
ISIN:        ZAE000016606
Summarised group income
statement for the
                          6 Months    6 Months    %       Year
                          ended 31    ended 31    Moveme  ended
                          March 2002  March 2001  nt      30
                          Unaudited   Unaudited           Septemb
                                      (revised)*          er 2001
                          R           R                   Audited
                                                          R
Investment income         2 897 687   1 956 298           4 614
                                                          384
- Interest received       164 130     418 188             659 681
- Dividends received      48 700      66 392              112 748
- Realised income -       91 244      295 065             402 813
marketable securities
- Unrealised income -     1 778 901   702 645             2 560
marketable securities                                     436
- Income from private     799 622     474 008             878 706
equity investments
- Other income            15 090      -                   -
Investment banking        808 069     1 300 400           1 319
income                                                    503
- Fees received           24 997      1 300 400           1 306
                                                          518
- Other income            783 072     -                   12 985
Insurance income          4 145 229   5 887 316           11 502
                                                          407
- Net premiums earned     3 656 082   5 012 731           9 402
                                                          698
- Commission received     86 926      123 804             218 514
- Fees received           23 259      166 091             764 385
- Interest received       497 386     584 690             1 116
                                                          810
- Unrealised loss -       (118 424)   -                   -
marketable securities
Total revenue             7 850 985   9 144 014   (14%)   17 436
                                                          294
Expenses attributable to  1 733 681   2 809 100           5 740
cell holders                                              451
Net underwriting          2 030 102   2 206 430           3 684
expenses and claims                                       151
incurred
Finance charges           109 302     11 661              26 640
Operating expenses        2 486 115   2 455 228           4 817
                                                          624
Total expenses            6 359 200   7 482 419   (15%)   14 268
                                                          866
Profit before taxation    1 491 785   1 661 595   (10%)   3 167
                                                          428
Taxation                  (371 579)   (398 642)           (832
                                                          327)
Profit from ordinary      1 120 206   1 262 953           2 335
activities                                                101
Minority shareholders'
interest in private       297 514     130 689             212 436
equity investments'
losses/profits
Net income attributable   1 417 720   1 393 642   2%      2 547
to ordinary shareholders                                  537
Dividends per share
(cents)
- paid                    3,75        -                   4,25
- declared                -           4,25                3,75
Headline earnings per     9,85        11,47       (14%)   19,75
share (cents)
Earnings per share        9,85        11,47       (14%)   17,07
(cents)
Fully diluted headline    9,85        9,68        2%      17,69
earnings per share
(cents)
Number of shares
- in issue                14 390 000  12 400 000          13 400
                                                          000
- weighted average (up    14 398 333  12 150 000          12 900
to 31 March 2002)                                         000
- fully diluted           14 390 000  14 400 000          14 400
                                                          000
Summarised group
balance sheet as at
                         31 March  31 March                  30
                         2002      2001                      September
                         Unaudited Unaudited                 2001
                                   (revised)*                Audited
                         R         R                         R
ASSETS
Non-current assets       13 084    9 828 113                 11 455
                         221                                 944
Property, plant and      842 561   1 033 774                 937 583
equipment
Intangible assets        434 576   457 319                   445 307
Goodwill                 -         308 462                   -
Other investments        6 602 530 3 018 104                 4 768 000
Loan to Indequity Group
Limited Employee Share   5 204 554 5 010 454                 5 305 054
Incentive Trust
Current assets           18 670    18 901 332                19 131
                         503                                 790
Marketable securities    6 182 100 2 607 831                 2 163 120
Receivables              933 094   432 657                   1 004 752
Cash and cash            11 555    15 860 844                15 963
equivalents              309                                 918
Total assets             31 754    28 729 445                30 587
                         724                                 734
EQUITY AND LIABILITIES
Capital and reserves
Share capital            14 390    14 400                    14 400
Share premium            19 342    19 353 800                19 353
                         732                                 800
Non distributable        15 514    -                         6 118
reserve
Retained income          4 541 267 3 430 188                 3 667 390
Shareholders' funds      23 913    22 798 388                23 041
                         903                                 708
Preferred shareholders'  3 607 080 2 562 367                 3 559 063
interest
Minority shareholders'   (845 077) (465 840)                 (547 586)
interest
Non-current liabilities  1 503 531 979 893                   1 206 308
Interest-bearing         362 017   171 440                   217 729
borrowings
Negative goodwill        553 924   808 453                   673 405
Deferred tax             587 590   -                         315 174
Technical insurance      1 566 521 1 529 991                 1 485 684
provisions
Net outstanding claims    1 551    1 529 991                 1 475 271
                         377
Net unearned premiums    15 144    -                         10 413
Current liabilities      2 008 766 1 324 646                 1 842 557
Trade payables           1 314 155 710 695                   812 947
Accruals and provisions  118 498   43 654                    520 000
Current tax liabilities  576 113   570 297                   509 610
Total equity and         31 754    28 729 445                30 587
liabilities              724                                 734
Net asset value per      1.66      1,84                      1.72
ordinary share (cents)
Statement of changes in
equity
                         Share     Retained    Non           Total
                         capital   income      distributable
                         and                   reserves
                         premium
Balance as at 1 October  19 368    3 667 390   6 118         23 041
2001                     200                                 708
Share buy back           (11 078)                            (11 078)
Net income after
taxation for the 6                 1 417 720                 1 417 720
months ended 31 March
2002
Dividends paid (final
for the year ended 30              (540 085)                 (540 085)
September 2001)
Transfer to contingency            (9 396)     9 396
reserve
Apportioned to                     5 638                     5 638
preference shareholders
Balance as at 31 March   19 357    4 541 267   15 514        23 913
2002                     122                                 903
Summarised cash flow
statement as at
                               31 March   31 March           30
                               2002       2001               September
                               Unaudited  Unaudited          2001
                               R          R                  Audited
                                                             R
Cash flow to operating         (462 499)  (160 450)          (1 307
activities                                                   458)
Cash flow to investment        (4 013     (7 502             (7 164
activities                     518)       473)               025)
Cash flow from/(to) financing  67 408     (5 843             (4 931
activities                                437)               803)
Net decrease in cash and cash  (4 408     (13 506            (13 403
equivalents                    609)       360)               286)
Cash and cash equivalents -    15 963     29 367             29 367
beginning of period/year       918        204                204
Cash and cash equivalents -    11 555     15 860             15 963
end of period/year             309        844                918
* The comparative figures (March 2001) have been adjusted to reflect
the following changes in the accounting policy adopted in the annual
financial statements for the year ended 30 September 2001:
the investment in Alexecovet (Pty) Ltd is accounted for as a
consolidated subsidiary and no longer as an associate company; and
the carrying amount of negative goodwill is adjusted by the reduction
in the contingency reserve which existed on the date of acquisition of
Indequity Specialised Insurance Limited.  Previously negative goodwill
were recognised as income over a maximum period of twenty years.
The interim financial report has been compiled in accordance with AC
127, Interim financial reporting.
Comments on results
Against the backdrop of a difficult economic climate, volatile equity
markets and general instability which prevailed for much of the period under
review, the Group is largely satisfied with the results for the six months
ended 31 March 2002.  Turnover decreased by 14% to R7,8 million whilst the
Group managed to reduce expenses by 15% to R6,4 million. The net result,
being net income attributable to ordinary shareholders of R1,4 million, is
in line with the results reflected in the comparative period. However, as a
result of an increase in the number of ordinary shares in issue to 14 390
000, headline earnings per share reflects a decrease of 14% to 9,85 cents.
Divisional results
Investments
The investments division continued to perform admirably. In accordance with
AC 133, investments in listed equities are recorded at market value with the
corresponding movement being reflected in the income statement as either
income or expense. The results of the Group's private equity investments are
consolidated.
It is also noteworthy that at 31 March 2002, the Group's investment
portfolio (including investments held by the Group's insurance company), at
cost, consisted of 54,6% in the money market, 26,3% in listed equities,
14,1% in Proper Group Ltd, and 5,0% in private equity investments.
 The decision to invest a larger portion of cash resources in listed
equities, in particular proved to have been a correct decision. Indequity
(SA) Capital Ltd, through which the largest portion of the Group's listed
investments are held, showed an annualised pre-tax return for the period of
30, 6% (Year to September 2001: 25,9%).
The Group's strategic investment in Proper Group Ltd was increased to an
effective stake of 18,57%. Although this investment also contributed
positively to earnings, the long-term prospects of our investment are
obviously directly linked to the performance of the company. The Group
noted, with concern, the profit warning which this company released during
March 2002. However, management is confident that problem areas will receive
the required attention and that they will be rectified.
The Group's private equity investment in Alexecovet (Pty) Ltd continued to
deliver negative results. Consequently, operational changes have been
implemented and the international expansion has been put on hold. The Group
remains confident that, once these measures are fully effective, it will
receive an acceptable return on its investment.  The Group's remaining
private equity investment, Cyan Communications (Pty) Ltd, is still in its
early growth phase. Whilst the Group's investment in Cyan is currently
immaterial in relation to the remainder of the Group, management is positive
about the medium to long-term prospects of Cyan.
Investment Banking
As indicated in our previous report to shareholders, the fortunes of this
division are strongly correlated to the general state of equity markets. The
decline in profits can therefore largely be attributed to this fact.
Nevertheless, the fact that this division managed to hold its own in such
trying market conditions, is testimony to management's commitment and
innovation.
Insurance
Management's focus during this period under review was directed mainly at
the expansion of the Group's insurance license into a full general insurance
license (as opposed to a cell captive license only). We are pleased to
confirm that this license was granted to Indequity Specialised Insurance Ltd
during March 2002.
Unfortunately as a result of this focus, management was unable to focus
their attention fully on the growth of its current book of business, which
explains the decrease in premiums and profitability of this division.
Nevertheless, the Group believes that it is now well positioned to offer a
more diverse product range and to be able to serve our clients better in
future.
Prospects
Although the results for the period under review reflect no growth in
profits, we remain committed to our objective to deliver above average
earnings growth over the longer term. But, looking forward, we do not expect
a predictable, stable pattern of increases every six months. Fluctuating
market conditions will continue to make it extremely difficult for the
Group, in all three of its divisions, to achieve the stability and
predictability of some businesses in other industries. However, the Group
intends to continue to build for the future and is continually striving to
increase the contribution of recurring and annuity income in order to create
a more stable earnings base.
Appointment of director
The Group has appointed Mr. Johan Zwarts as a non-executive director with
effect from 13 December 2001. We welcome him and look forward to his
contribution to the Group.
Dividends
In accordance with the Group's current cash requirements, in order to
increase the capital base of Indequity Specialised Insurance Ltd, no
dividend is declared for the current period.
On behalf of the board
L J van Rensburg      T C Meyer          Johannesburg
Chief Executive       Director           23 April 2002
Officer
Directors: A V van Jaarsveldt* (British), L J van Rensburg, T C Meyer, B J
Slabbert*, J F Zwarts* (*non-executive) Company secretary:  S le Roux
Registered address: First Floor, Cascade House, Constantia Office Park, cnr
14th Avenue and Hendrik Potgieter Road, Constantia Kloof, 1709 Postal
address: PO Box 5433, Weltevredenpark, 1715 Telephone: (+27 11) 475-0816
Fax: (+27 11) 475-0877 Website: www.indequity.com

Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: